FDA Redesigns Infant Formula Resource Page

The U.S. Food and Drug Administration (FDA) published a redesigned webpage to better organize content related to infant formula. The page is intended to help both consumers and industry access information more easily.

In March 2023, the FDA released an Immediate National Strategy to Increase the Resiliency of the U.S. Infant Formula Market. FDA released the strategy in response to the infant formula shortage in 2022 that was sparked by insanitary conditions at one of the nation’s largest infant formula facilities, which led to a large-scale voluntary recall and a multiple-month facility shutdown. The strategy described immediate actions the FDA took to address the infant formula shortage and detailed the agency’s plans for improving the resiliency of the infant formula supply, while noting multiple issues beyond the purview of the FDA.

As part of the strategy, the FDA committed to consolidating and reorganizing infant formula information on FDA.gov. The release of the redesigned resource page is a first step toward improving accessibility of information to help parents, caregivers and industry get the information they need about infant formula.

In addition, the agency released a number of materials to help consumers and other stakeholders better understand Cronobacter sakazakii, the pathogen that has been at the center of a number of recent recalls of powdered infant formula. These materials included a blog, a new webpage and an infographic.